Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case–control study in Brazil

By Nascimento L. V.  

Annals of Tropical Medicine and Parasitology, Vol. 95, Iss. 6, 2001-09 ,pp. : 587-593

Routledge Ltd

Access to resources Recommend Favorite

Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients

By  

Oncology Research and Treatment, Vol. 40, Iss. 3, 2017-02 ,pp. : 120-127

Karger

Access to resources Recommend Favorite

Genotyping of CYP2B6 and therapeutic drug monitoring in an HIV-infected patient with high efavirenz plasma concentrations and severe CNS side-effects

By Mathiesen Sofie   Stenz Justesen Ulrik   Von Lüttichau Hans-Rudolf   Eg Hansen Ann-Brit  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 8, 2006-08 ,pp. : 733-735

Informa Healthcare

Access to resources Recommend Favorite

Drug-Resistant Tuberculosis in HIV-Infected Persons: Italy 1999–2000

By Vanacore P.   Koehler B.   Carbonara S.   Zacchini F.   Bassetti D.   Antonucci G.   Ippolito G.   Girardi E.  

Infection, Vol. 32, Iss. 6, 2004-12 ,pp. : 328-332

Springer Publishing Company

Access to resources Recommend Favorite

Homelessness and Adherence to Antiretroviral Therapy among a Cohort of HIV-Infected Injection Drug Users

By Palepu Anita  

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 88, Iss. 3, 2011-06 ,pp. : 545-555

Springer Publishing Company

Access to resources Recommend Favorite